Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10385)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 26, 2019 (publication date) through Dec 12, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kenda Suster N, Virant-Klun I. Presence and role of stem cells in ovarian cancer. World J Stem Cells 2019; 11(7): 383-397 [PMID: 31396367 DOI: 10.4252/wjsc.v11.i7.383] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v11/i7/383.htm |
| Number | Citing Articles |
| 1 |
Maritza P. Garrido, Allison N. Fredes, Lorena Lobos-González, Manuel Valenzuela-Valderrama, Daniela B. Vera, Carmen Romero. Current Treatments and New Possible Complementary Therapies for Epithelial Ovarian Cancer. Biomedicines 2021; 10(1): 77 doi: 10.3390/biomedicines10010077
|
| 2 |
Prachitee Borkar, Prasan Bhandari, Shraddha Yadav, Ashwini Prabhu. Cisplatin Resistance in Ovarian Cancer: Classical Outlook and Newer Perspectives. Biomedical and Pharmacology Journal 2021; 14(4): 1993 doi: 10.13005/bpj/2297
|
| 3 |
Nataša Kenda Šuster. Stem Cells in Reproductive Tissues and Organs. Stem Cell Biology and Regenerative Medicine 2022; 70: 109 doi: 10.1007/978-3-030-90111-0_5
|
| 4 |
Zhongkang Li, Haihan Gu, Xiaotong Xu, Yanpeng Tian, Xianghua Huang, Yanfang Du. Unveiling the novel immune and molecular signatures of ovarian cancer: insights and innovations from single-cell sequencing. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1288027
|
| 5 |
Unedo Hence Markus Sihombing, Andrijono Andrijono, Gatot Purwoto, Supriadi Gandamihardja, Alida R. Harahap, Primariadewi Rustamadji, Aria Kekalih, Retno Widyawati, Dzicky Rifqi Fuady. CD44+/CD24- Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study. Journal of the Egyptian National Cancer Institute 2022; 34(1) doi: 10.1186/s43046-022-00143-2
|
| 6 |
Shahil Alam, Pankaj Kumar Giri. Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors. Cancer Drug Resistance 2024; doi: 10.20517/cdr.2023.152
|
| 7 |
Ji Eun Kwon, Yeonsue Jang, Bo Seong Yun, Suki Kang, Yon Hee Kim, Baek Gil Kim, Nam Hoon Cho. MET overexpression in ovarian cancer via CD24‐induced downregulation of miR‐181a: A signalling for cellular quiescence‐like state and chemoresistance in ovarian CSCs. Cell Proliferation 2024; 57(5) doi: 10.1111/cpr.13582
|
| 8 |
Jing Guo, Xiaozhu Zeng, Yongjie Zhu, Dong Yang, Xudong Zhao. Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05174-y
|
| 9 |
Jin Gu Cho, Sung-wook Kim, Aram Lee, Ha-neul Jeong, Eunsik Yun, Jihea Choi, Su Jin Jeong, Woochul Chang, Sumin Oh, Kyung Hyun Yoo, Jung Bok Lee, Sukjoon Yoon, Myeong-Sok Lee, Jong Hoon Park, Min Hyung Jung, So-Woon Kim, Ki Hyung Kim, Dong Soo Suh, Kyung Un Choi, Jungmin Choi, Jongmin Kim, Byung Su Kwon. MicroRNA-dependent inhibition of WEE1 controls cancer stem-like characteristics and malignant behavior in ovarian cancer. Molecular Therapy - Nucleic Acids 2022; 29: 803 doi: 10.1016/j.omtn.2022.08.028
|
| 10 |
Adam C. Fields, Pamela W. Lu, George Z. Li, Vanessa Welten, Joshua S. Jolissaint, Benjamin M. Vierra, Lily V Saadat, Abby C. Larson, Rachel B. Atkinson, Nelya Melnitchouk. Current practices and future steps for hyperthermic intraperitoneal chemotherapy. Current Problems in Surgery 2020; 57(3): 100727 doi: 10.1016/j.cpsurg.2019.100727
|
| 11 |
Deepa Bhartiya, Hiren Patel, Ankita Kaushik, Pushpa Singh, Diksha Sharma. Endogenous, tissue-resident stem/progenitor cells in gonads and bone marrow express FSHR and respond to FSH via FSHR-3. Journal of Ovarian Research 2021; 14(1) doi: 10.1186/s13048-021-00883-0
|
| 12 |
Zaineb Javed, Beth Worley, Coryn Stump, Sara Shimko, LaTaijah Crawford, Karthikeyan Mythreye, Nadine Hempel. Optimization of Extracellular Flux Assay to Measure Respiration of Anchorage-independent Tumor Cell Spheroids. BIO-PROTOCOL 2022; 12(4) doi: 10.21769/BioProtoc.4321
|
| 13 |
Shruthi Sriramkumar, Tara X. Metcalfe, Tim Lai, Xingyue Zong, Fang Fang, Heather M. O’Hagan, Kenneth P. Nephew, Lawrence M. Pfeffer. Single-cell analysis of a high-grade serous ovarian cancer cell line reveals transcriptomic changes and cell subpopulations sensitive to epigenetic combination treatment. PLOS ONE 2022; 17(8): e0271584 doi: 10.1371/journal.pone.0271584
|
| 14 |
Aleksandra Englisz, Marta Smycz-Kubańska, Aleksandra Mielczarek-Palacz. Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer. Diagnostics 2023; 13(10): 1714 doi: 10.3390/diagnostics13101714
|
| 15 |
Patrycja Królewska‑Daszczyńska, Dominika Wendlocha, Marta Smycz‑Kubańska, Sebastian Stępień, Aleksandra Mielczarek‑palacz. Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review). Oncology Letters 2022; 24(6) doi: 10.3892/ol.2022.13585
|
| 16 |
Dinh-Toi Chu, Suong Mai Vu Ngoc, Yen-Vy Nguyen Thi, Mai-Anh Nguyen, Binh Pham Van, Le Tri Chinh, Pham Gia Anh. . Interdisciplinary Cancer Research 2023; doi: 10.1007/16833_2022_123
|
| 17 |
Gautham Chengizkhan, Bharti Bisht, Sridhar Muthusami, Muralidharan Anbalagan, Ilangovan Ramachandran, R. Ileng Kumaran. Cancer Stem Cells: New Horizons in Cancer Therapies. 2020; : 15 doi: 10.1007/978-981-15-5120-8_2
|
| 18 |
Agnieszka Szyposzynska, Aleksandra Bielawska-Pohl, Maria Paprocka, Julia Bar, Marek Murawski, Aleksandra Klimczak. Comparative Analysis of Primary Ovarian Cancer Cells and Established Cell Lines as a New Tool for Studies on Ovarian Cancer Cell Complexity. International Journal of Molecular Sciences 2024; 25(10): 5384 doi: 10.3390/ijms25105384
|
| 19 |
Ana Pertejo Fernández, Jorge Pedregosa Barbas, Beatriz Castelo Fernández, Andrés Redondo Sánchez. Ovarian cancer: epidemiology and natural history. Revisiones en Cáncer 2024; doi: 10.20960/revcancer.00087
|
| 20 |
Yan Li, Juan Wang, Fang Wang, Wenyu Chen, Chengzhen Gao, Jianhua Wang. RNF144A suppresses ovarian cancer stem cell properties and tumor progression through regulation of LIN28B degradation via the ubiquitin-proteasome pathway. Cell Biology and Toxicology 2022; 38(5): 809 doi: 10.1007/s10565-021-09609-w
|
| 21 |
Terrence MacArthur Pugh, Vishwa S. Raj, Charles Mitchell. Breast Cancer and Gynecologic Cancer Rehabilitation. 2021; : 263 doi: 10.1016/B978-0-323-72166-0.00023-2
|
| 22 |
Young Joo Lee, Sung Wook Kim, Min Hyung Jung, Young Sun Kim, Kyung Sook Kim, Dong Soo Suh, Ki Hyung Kim, Eun Ha Choi, Jongmin Kim, Byung Su Kwon. Plasma-activated medium inhibits cancer stem cell-like properties and exhibits a synergistic effect in combination with cisplatin in ovarian cancer. Free Radical Biology and Medicine 2022; 182: 276 doi: 10.1016/j.freeradbiomed.2022.03.001
|
| 23 |
Deepa Bhartiya, Sherif Raouf, Kshama Pansare, Anish Tripathi, Ashish Tripathi. Initiation of Cancer: The Journey From Mutations in Somatic Cells to Epigenetic Changes in Tissue-resident VSELs. Stem Cell Reviews and Reports 2024; 20(4): 857 doi: 10.1007/s12015-024-10694-7
|
| 24 |
Eric N. Horst, Michael E. Bregenzer, Pooja Mehta, Catherine S. Snyder, Taylor Repetto, Yang Yang-Hartwich, Geeta Mehta. Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model. Acta Biomaterialia 2021; 132: 401 doi: 10.1016/j.actbio.2021.04.041
|
| 25 |
Jacek R Wilczyński, Miłosz Wilczyński, Edyta Paradowska. Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies. International Journal of Molecular Sciences 2022; 23(5): 2496 doi: 10.3390/ijms23052496
|
| 26 |
Michal Kielbik, Patrycja Przygodzka, Izabela Szulc-Kielbik, Magdalena Klink. Snail transcription factors as key regulators of chemoresistance, stemness and metastasis of ovarian cancer cells. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878(6): 189003 doi: 10.1016/j.bbcan.2023.189003
|
| 27 |
Chao Lien Liu, Ying Jen Chen, Ming Huei Fan, Yi Jen Liao, Tsui Lien Mao. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma. International Journal of Molecular Sciences 2020; 21(18): 6467 doi: 10.3390/ijms21186467
|
| 28 |
Yan Yang, Guangming Zhu, Li Yang, Yun Yang. Targeting CD24 as a novel immunotherapy for solid cancers. Cell Communication and Signaling 2023; 21(1) doi: 10.1186/s12964-023-01315-w
|
| 29 |
Wookyeom Yang, Dasol Kim, Dae Kyoung Kim, Kyung Un Choi, Dong Soo Suh, Jae Ho Kim. Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells. International Journal of Molecular Sciences 2021; 22(10): 5059 doi: 10.3390/ijms22105059
|
| 30 |
Lingling Yang, Muyao Yang, Chenxi Cui, Xingtao Long, Yunzhe Li, Weili Dai, Tingyuan Lang, Qi Zhou. The myo-inositol biosynthesis rate-limiting enzyme ISYNA1 suppresses the stemness of ovarian cancer via Notch1 pathway. Cellular Signalling 2023; 107: 110688 doi: 10.1016/j.cellsig.2023.110688
|
| 31 |
Expression of CD44+/CD24-, RAD6 and DDB2 on chemotherapy response in ovarian Cancer: A prospective flow cytometry study. Gynecologic Oncology Reports 2022; 42: 101005 doi: 10.1016/j.gore.2022.101005
|
| 32 |
Deepa Bhartiya, Ankita Kaushik. Testicular Stem Cell Dysfunction Due to Environmental Insults Could Be Responsible for Deteriorating Reproductive Health of Men. Reproductive Sciences 2021; 28(3): 649 doi: 10.1007/s43032-020-00411-3
|
| 33 |
Lin-Lin Chang, Xia-Qing Xu, Xue-Ling Liu, Qian-Qian Guo, Yan-Nan Fan, Bao-Xia He, Wen-Zhou Zhang. Emerging role of m6A methylation modification in ovarian cancer. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02371-3
|
| 34 |
Basharat Ahmad Bhat, Ifra Saifi, Nizar A. Khamjan, Syed Suhail Hamdani, Abdullah Algaissi, Safeena Rashid, Mohammed M. Alshehri, Showkat Ahmad Ganie, Mohtashim Lohani, Siddig Ibrahim Abdelwahab, Sajad Ahmad Dar. Exploring the tumor immune microenvironment in ovarian cancer: a way-out to the therapeutic roadmap. Expert Opinion on Therapeutic Targets 2023; 27(9): 841 doi: 10.1080/14728222.2023.2259096
|
| 35 |
Eun Jung Sohn. Differentially expression and function of circular RNAs in ovarian cancer stem cells. Journal of Ovarian Research 2022; 15(1) doi: 10.1186/s13048-022-01014-z
|
| 36 |
Matthew Masoudi, Vinod Gopalan. Cancer Stem Cells: Basic Concept and Therapeutic Implications. 2023; : 149 doi: 10.1007/978-981-99-3185-9_9
|
| 37 |
Arunita Ghosh, Ken Jaaback, Angela Boulton, Michelle Wong-Brown, Steve Raymond, Partha Dutta, Nikola A. Bowden, Arnab Ghosh. Fusobacterium nucleatum: An Overview of Evidence, Demi-Decadal Trends, and Its Role in Adverse Pregnancy Outcomes and Various Gynecological Diseases, including Cancers. Cells 2024; 13(8): 717 doi: 10.3390/cells13080717
|
| 38 |
Beatrice Aramini, Valentina Masciale, Giulia Grisendi, Federica Bertolini, Michela Maur, Giorgia Guaitoli, Isca Chrystel, Uliano Morandi, Franco Stella, Massimo Dominici, Khawaja Husnain Haider. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence. Cancers 2022; 14(4): 976 doi: 10.3390/cancers14040976
|
| 39 |
Rachel Ringquist, Delta Ghoshal, Ritika Jain, Krishnendu Roy. Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models. Advanced Drug Delivery Reviews 2021; 179: 114003 doi: 10.1016/j.addr.2021.114003
|
| 40 |
Aleksandra Śliwa, Anna Szczerba, Paweł Piotr Pięta, Piotr Białas, Jakub Lorek, Ewa Nowak-Markwitz, Anna Jankowska. A Recipe for Successful Metastasis: Transition and Migratory Modes of Ovarian Cancer Cells. Cancers 2024; 16(4): 783 doi: 10.3390/cancers16040783
|
| 41 |
Heming Long, Hongmei Chen, Jun Yan, Haiyan Cheng. Emodin exerts antitumor effects in ovarian cancer cell lines by preventing the development of cancer stem cells via epithelial mesenchymal transition. Oncology Letters 2022; 23(3) doi: 10.3892/ol.2022.13215
|
| 42 |
Esther Schoutrop, Lidia Moyano-Galceran, Stephanie Lheureux, Jonas Mattsson, Kaisa Lehti, Hanna Dahlstrand, Isabelle Magalhaes. Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment. Seminars in Cancer Biology 2022; 86: 207 doi: 10.1016/j.semcancer.2022.03.027
|
| 43 |
Karolina Frąszczak, Bartłomiej Barczyński. The Role of Cancer Stem Cell Markers in Ovarian Cancer. Cancers 2023; 16(1): 40 doi: 10.3390/cancers16010040
|
| 44 |
Fumiya Tomizawa, Myung-Kyu Jang, Tetsuo Mashima, Hiroyuki Seimiya. c-KIT regulates stability of cancer stemness in CD44-positive colorectal cancer cells. Biochemical and Biophysical Research Communications 2020; 527(4): 1014 doi: 10.1016/j.bbrc.2020.05.024
|
| 45 |
Hai-Long Liu, Ya-Nan Wang, Shi-Yu Feng. Brain tumors: Cancer stem-like cells interact with tumor microenvironment. World Journal of Stem Cells 2020; 12(12): 1439-1454 doi: 10.4252/wjsc.v12.i12.1439
|
| 46 |
Haider Ali Malakzai, Jamshid Abdul-Ghafar, Abdul Sami Ibrahimkhil, Ahmed Maseh Haidary. A rare ovarian hilus cell tumour accompanying bilateral serous cystadenomas: report of a case. Journal of Ovarian Research 2021; 14(1) doi: 10.1186/s13048-021-00833-w
|
| 47 |
Zhiqing Huang, Olivia Byrd, Sarah Tan, Katrina Hu, Bailey Knight, Gaomong Lo, Lila Taylor, Yuan Wu, Andrew Berchuck, Susan K. Murphy. Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-48485-8
|
| 48 |
Alia Ghoneum, Daniela Gonzalez, Ammar Yasser Abdulfattah, Neveen Said. Metabolic Plasticity in Ovarian Cancer Stem Cells. Cancers 2020; 12(5): 1267 doi: 10.3390/cancers12051267
|
| 49 |
Dinh-Toi Chu, Mai Vu Ngoc Suong, Hue Vu Thi, Thuy-Duong Vu, Manh-Hung Nguyen, Vijai Singh. The expression and mutation of BRCA1/2 genes in ovarian cancer: a global systematic study. Expert Review of Molecular Diagnostics 2023; 23(1): 53 doi: 10.1080/14737159.2023.2168190
|
| 50 |
Andrzej Nowicki, Magdalena Kulus, Maria Wieczorkiewicz, Wojciech Pieńkowski, Katarzyna Stefańska, Paulina Skupin-Mrugalska, Rut Bryl, Paul Mozdziak, Bartosz Kempisty, Hanna Piotrowska-Kempisty. Ovarian Cancer and Cancer Stem Cells—Cellular and Molecular Characteristics, Signaling Pathways, and Usefulness as a Diagnostic Tool in Medicine and Oncology. Cancers 2021; 13(16): 4178 doi: 10.3390/cancers13164178
|
| 51 |
Maria Luisa Calabrò, Nayana Lazzari, Giulia Rigotto, Marco Tonello, Antonio Sommariva. Role of Epithelial–Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments. International Journal of Molecular Sciences 2020; 21(23): 9120 doi: 10.3390/ijms21239120
|
| 52 |
Jacek R. Wilczyński. Interaction of Immune and Cancer Cells. Experientia Supplementum 2022; 113: 219 doi: 10.1007/978-3-030-91311-3_8
|
| 53 |
Sharmistha Chatterjee, Abhishek Kumar Das, Parames C. Sil. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. 2021; : 1 doi: 10.1007/978-981-15-4501-6_123-1
|
| 54 |
Vahideh Keyvani, Espanta Riahi, Meysam Yousefi, Seyed-Alireza Esmaeili, Rana Shafabakhsh, Amin Moradi Hasan-Abad, Maryam Mahjoubin-Tehran, Michael R. Hamblin, Samaneh Mollazadeh, Hamed Mirzaei. Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.823572
|
| 55 |
Lubna Therachiyil, Ola J. Hussein, Shahab Uddin, Hesham M. Korashy. Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways. Seminars in Cancer Biology 2022; 86: 1186 doi: 10.1016/j.semcancer.2022.10.003
|
| 56 |
Deepa Bhartiya, Pushpa Singh, Ankita Kaushik, Diksha Sharma. Stem Cells in Reproductive Tissues and Organs. Stem Cell Biology and Regenerative Medicine 2022; 70: 263 doi: 10.1007/978-3-030-90111-0_12
|
| 57 |
Natalia Izycka, Marcin Rucinski, Malgorzata Andrzejewska, Sebastian Szubert, Ewa Nowak-Markwitz, Karolina Sterzynska. The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients. International Journal of Molecular Sciences 2023; 24(3): 2400 doi: 10.3390/ijms24032400
|
| 58 |
Farzaneh Ghaderi, Narges Jokar, Ali Gholamrezanezhad, Majid Assadi, Hojjat Ahmadzadehfar. Toward radiotheranostics in cancer stem cells: a promising initial step for tumour eradication. Clinical and Translational Imaging 2021; 9(6): 561 doi: 10.1007/s40336-021-00444-x
|
| 59 |
Deepa Bhartiya, Diksha Sharma. VSELs and OSCs together sustain oogenesis in adult ovaries and their dysfunction results in age-related senescence, PCOS, POI and cancer. Journal of Ovarian Research 2023; 16(1) doi: 10.1186/s13048-022-01093-y
|
| 60 |
Carlotta Sabini, Flavia Sorbi, Paula Cunnea, Christina Fotopoulou. Ovarian cancer stem cells: ready for prime time?. Archives of Gynecology and Obstetrics 2020; 301(4): 895 doi: 10.1007/s00404-020-05510-9
|
| 61 |
Diksha Sharma, Deepa Bhartiya. Stem Cells in Adult Mice Ovaries Form Germ Cell Nests, Undergo Meiosis, Neo-oogenesis and Follicle Assembly on Regular Basis During Estrus Cycle. Stem Cell Reviews and Reports 2021; 17(5): 1695 doi: 10.1007/s12015-021-10237-4
|
| 62 |
Sharmistha Chatterjee, Abhishek Kumar Das, Parames C. Sil. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. 2022; : 1855 doi: 10.1007/978-981-15-9411-3_123
|
| 63 |
Ravi Gor, Ilangovan Ramachandran, Satish Ramalingam. Targeting the Cancer Stem Cells in Endocrine Cancers with Phytochemicals. Current Topics in Medicinal Chemistry 2022; 22(31): 2589 doi: 10.2174/1567205020666221114112814
|
| 64 |
Saeedeh Keyvani-Ghamsari, Khatereh Khorsandi, Azhar Rasul, Muhammad Khatir Zaman. Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance. Clinical Epigenetics 2021; 13(1) doi: 10.1186/s13148-021-01107-4
|
| 65 |
Yao-An Shen, Chang-Cyuan Chen, Bo-Jung Chen, Yu-Ting Wu, Jiun-Ru Juan, Liang-Yun Chen, Yueh-Chun Teng, Yau-Huei Wei. Potential Therapies Targeting Metabolic Pathways in Cancer Stem Cells. Cells 2021; 10(7): 1772 doi: 10.3390/cells10071772
|